NCT05315713 2024-10-04An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin LymphomaHoffmann-La RochePhase 1/2 Terminated8 enrolled 12 charts